Pivotal Therapeutics Inc.
PVTTF
OTC PK
| 09/30/2015 | 06/30/2015 | ||||
|---|---|---|---|---|---|
| Revenue | 1,108.75% | -106.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1,108.75% | -106.45% | |||
| Cost of Revenue | -40.78% | 14.01% | |||
| Gross Profit | 370.66% | -123.92% | |||
| SG&A Expenses | -17.95% | -9.44% | |||
| Depreciation & Amortization | -5.88% | 2.12% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.01% | -9.67% | |||
| Operating Income | 31.83% | -11.48% | |||
| Income Before Tax | 31.41% | -22.87% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 31.41% | -22.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 31.41% | -22.87% | |||
| EBIT | 31.83% | -11.48% | |||
| EBITDA | 33.07% | -11.97% | |||
| EPS Basic | 32.00% | -21.36% | |||
| Normalized Basic EPS | 32.05% | -21.88% | |||
| EPS Diluted | 32.00% | -21.36% | |||
| Normalized Diluted EPS | 32.05% | -21.88% | |||
| Average Basic Shares Outstanding | 0.06% | 1.39% | |||
| Average Diluted Shares Outstanding | 0.06% | 1.39% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||